Literature DB >> 22228879

Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy.

Juan Francisco Rivera Ramos1, Celina Rodríguez Leal.   

Abstract

Hepatic encephalopathy (HE) is a heterogeneous disease that develops as a result of serious liver disease, such as in fulminant hepatitis or cirrhosis, or a portosystemic shunt. It manifests as a spectrum of abnormalities involving cognition, attention, functional ability, personality and intellect. The neuropsychiatric impairment associated with HE can range from mild alteration of cognition and consciousness to coma, depending on the stage of the illness. In 1998, the World Gastroenterology Organization formed a working party to develop guidelines and recommendations for the diagnosis, grading and treatment of HE for research and practice. In this report, we discuss the various tests available for diagnosis and grading and the recommendations of the working party, which provide a framework for further studies on clinical trial methodology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22228879

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  6 in total

Review 1.  Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?

Authors:  Lise Lotte Gluud; Gitte Dam; Mette Borre; Iñigo Les; Juan Cordoba; Giulio Marchesini; Niels Kristian Aagaard; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2012-12-29       Impact factor: 3.584

2.  Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification.

Authors:  Paolo Fonio; Andrea Discalzi; Marco Calandri; Andrea Doriguzzi Breatta; Laura Bergamasco; Silvia Martini; Antonio Ottobrelli; Dorico Righi; Giovanni Gandini
Journal:  Radiol Med       Date:  2017-05-16       Impact factor: 3.469

Review 3.  Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

Review 4.  Organic delirious states and other psychiatric disorders: lessons for the hepatologists.

Authors:  Raben Rosenberg; Signe Groth Renvillard; Simon Hjerrild
Journal:  Metab Brain Dis       Date:  2012-11-06       Impact factor: 3.584

5.  Is propofol safe when administered to cirrhotic patients during sedative endoscopy?

Authors:  Sang Jun Suh; Hyung Joon Yim; Eileen L Yoon; Beom Jae Lee; Jong Jin Hyun; Sung Woo Jung; Ja Seol Koo; Ji Hoon Kim; Kyung Jin Kim; Rok Son Choung; Yeon Seok Seo; Jong Eun Yeon; Soon Ho Um; Kwan Soo Byun; Sang Woo Lee; Jai Hyun Choi; Ho Sang Ryu
Journal:  Korean J Intern Med       Date:  2014-01-02       Impact factor: 2.884

6.  The abnormality of thyroid hormones in patients with type A hepatic encephalopathy.

Authors:  Lin Wang; Wanyou Yu; Wukui Cao; Wei Lu
Journal:  Oncotarget       Date:  2017-06-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.